Zobrazeno 1 - 10
of 649
pro vyhledávání: '"Eric M, Yoshida"'
Autor:
Mohammad Honarvar, Julio Lobo, Caitlin Schneider, Samuel Klein, Gordon I. Smith, Rohit Loomba, Alnoor Ramji, Tarek Hassanein, Eric M. Yoshida, Emily Pang, Michael P. Curry, Nezam H. Afdhal
Publikováno v:
WFUMB Ultrasound Open, Vol 2, Iss 2, Pp 100061- (2024)
Introduction: As prevalence of patients with steatotic liver diseases increases throughout the world, it is necessary to have accurate and accessible methods to estimate liver fat content. Using quantitative ultrasound parameters, such as attenuation
Externí odkaz:
https://doaj.org/article/7de839a8c75b49dab257ace0a800fd48
Autor:
Chenoa Cassidy-Matthews, Margo Pearce, Trana Hussaini, Patricia Spittal, Nadine Caron, Cole Daley, Ruth Alfred, Eric M. Yoshida
Publikováno v:
International Journal of Circumpolar Health, Vol 83, Iss 1 (2024)
ABSTRACTIndigenous Peoples in Canada face healthcare inequities impacting access to solid organ transplantation. The experiences of Indigenous patients during the liver transplant process, and how transplant professionals perceive challenges faced by
Externí odkaz:
https://doaj.org/article/a2be3b1b94384394bb487a230b13fd71
Autor:
Jean Damascene Makuza, Dahn Jeong, Stanley Wong, Mawuena Binka, Prince Asumadu Adu, Héctor Alexander Velásquez García, Richard L. Morrow, Georgine Cua, Amanda Yu, Maria Alvarez, Sofia Bartlett, Hin Hin Ko, Eric M. Yoshida, Alnoor Ramji, Mel Krajden, Naveed Zafar Janjua
Publikováno v:
The Lancet Regional Health. Americas, Vol 36, Iss , Pp 100826- (2024)
Summary: Background: We evaluated the association of hepatitis B virus (HBV) treatment with all-cause, and liver-related mortality among individuals with HBV and cirrhosis in British Columbia (BC), Canada. Methods: This analysis included people diagn
Externí odkaz:
https://doaj.org/article/645343e1635241beb792a883b3708884
Autor:
Vincent C. Tam, Ravi Ramjeesingh, Ronald Burkes, Eric M. Yoshida, Sarah Doucette, Howard J. Lim
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7072-7085 (2022)
Biliary tract cancer (BTC) is a group of rare and aggressive malignancies with a dismal prognosis. There is currently a significant lack in effective treatment options for BTC, with gemcitabine-cisplatin remaining the first-line standard of care trea
Externí odkaz:
https://doaj.org/article/c735cb9d60984c4192f079cf2016bd9c
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 28, Iss 2, Pp 85-91 (2022)
The use of N-acetylcysteine (NAC) for non-acetaminophen-induced acute liver failure (NAI-ALF) has been increasing despite controversy in its efficacy. National guidelines are in disagreement for NAC use as standard of care; however, many healthcare c
Externí odkaz:
https://doaj.org/article/db8b07b39485441b9568e848e1b98d6f
Autor:
Surain B. Roberts, Marwa Ismail, Gowthami Kanagalingam, Andrew L. Mason, Mark G. Swain, Catherine Vincent, Eric M. Yoshida, Cynthia Tsien, Jennifer A. Flemming, Harry L.A. Janssen, Gideon M. Hirschfield, Bettina E. Hansen, Aliya F. Gulamhusein, the Canadian Network for Autoimmune Liver Disease
Publikováno v:
Hepatology Communications, Vol 4, Iss 9, Pp 1332-1345 (2020)
Patients with primary biliary cholangitis (PBC) with incomplete response to ursodeoxycholic acid are at risk of disease progression and need additional therapy. Obeticholic acid (OCA) was approved in Canada in May 2017, but its effectiveness in a rea
Externí odkaz:
https://doaj.org/article/0b61f127e4ca4dbfb8963ff2a0226bb9
Autor:
Hanyang Lin, Zhaohui Bai, Fanjun Meng, Yanyan Wu, Li Luo, Akash Shukla, Eric M. Yoshida, Xiaozhong Guo, Xingshun Qi
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
BackgroundPatients with inflammatory bowel disease (IBD) may be at risk of developing portal venous system thrombosis (PVST) with worse outcomes. This study aims to explore the prevalence, incidence, and risk factors of PVST among patients with IBD.M
Externí odkaz:
https://doaj.org/article/f57aa30d259a4108af189ee037c88241
Autor:
Jennifer J. Lin, Catrina M. Loucks, Jessica N. Trueman, Britt I. Drögemöller, Galen E.B. Wright, Eric M. Yoshida, Jo-Ann Ford, Samuel S. Lee, Richard B. Kim, Bandar Al-Judaibi, Ute I. Schwarz, Alnoor Ramji, Edward Tam, Colin J. Ross, Bruce C. Carleton
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 143, Iss , Pp 112195- (2021)
Background: The current use of ribavirin in difficult-to-cure chronic hepatitis C patients (HCV) and patients with severe respiratory infections is constrained by the issue of ribavirin-induced hemolytic anemia that affects 30% of treated patients, r
Externí odkaz:
https://doaj.org/article/724bec238097474e9902ca6969efc72e
Autor:
Kristen M. Kidson, MD, FRCPC, Jeieung Park, MD, FRCPC, Marthe K. Charles, MD, MSc, FRCPC, Mahmoud Omar, MD, MSc, Mel Krajden, MD, FRCPC, Alissa J. Wright, MD, MSc, FRCPC, Trana Hussaini, PharmD, Peter T. W. Kim, MD, MSc, FRCSC, Stephen W. Chung, MD, PhD, FRCSC, Eric M. Yoshida, MD, MHSc, FRCPC
Publikováno v:
Transplantation Direct, Vol 7, Iss 10, p e747 (2021)
Current liver transplantation societies recommend recipients with active coronavirus disease 2019 (COVID-19) be deferred from transplantation for at least 2 wks, have symptom resolution and at least 1 negative severe acute respiratory syndrome corona
Externí odkaz:
https://doaj.org/article/239b0482c6b949448c1d1b1feea2c1a6
Autor:
Jean Damascene Makuza, Dahn Jeong, Mawuena Binka, Prince Asumadu Adu, Georgine Cua, Amanda Yu, Héctor Alexander Velásquez García, Maria Alvarez, Stanley Wong, Sofia Bartlett, Mohammad Ehsanul Karim, Eric M. Yoshida, Alnoor Ramji, Mel Krajden, Naveed Zafar Janjua
Publikováno v:
Viruses, Vol 14, Iss 11, p 2579 (2022)
Data on the contribution of hepatitis B virus (HBV) infection and related comorbidities to liver-related mortality in Canada are limited. We assessed the concurrent impact of HBV infection, non-alcoholic fatty liver disease (NAFLD), and hepatitis C v
Externí odkaz:
https://doaj.org/article/aa3208d1a4574455bbeaa92e952fc40a